The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mokrysheva N.G.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Mirnaia S.S.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF, Moskva

Dobreva E.A.

Endocrinology Research Centrer

Maganeva I.S.

Endocrinology Research Centre, Moscow, Russia

Kovalevа E.V.

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia

Krupinova Yu.A.

Endocrinology Research Centre, Moscow, Russia

Kriukova I.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Tevosyan L.Kh.

M.F. Vladimirskiy Moscow Regional Research and Clinical Institute, Moscow, Russia

Lukyanov S.V.

Rostov state medical university, Rostov-on-Don, Russia

Markina N.V.

Éndokrinologicheskiĭ dispanser Departamenta zdravookhraneniia Moskvy

Bondar' I.A.

Kafedra éndokrinologii Novosibirskogo gosudarstvennogo meditsinskogo universiteta

Podprugina N.G.

Nizhny Novgorod City hospital #33, Nizhny Novgorod, Russia

Ignatieva I.A.

Nizhny Novgorod City hospital #33, Nizhny Novgorod, Russia

Shabel’nikova O.Yu.

Novosibirsk State Medical University, Ministry of Healthcare of the Russian Federation, Novosibirsk, Russia;
Novosibirsk State Regional Clinical Hospital, Novosibirsk, Russia

Dreval' A.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Antsiferov M.B.

Éndokrinologicheskiĭ dispanser Departamenta zdravookhraneniia Moskvy

Melnichenko G.A.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia;
Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia

Dedov I.I.

Endocrinology Research Centre

Primary hyperparathyroidism in Russia according to the registry

Authors:

Mokrysheva N.G., Mirnaia S.S., Dobreva E.A., Maganeva I.S., Kovalevа E.V., Krupinova Yu.A., Kriukova I.V., Tevosyan L.Kh., Lukyanov S.V., Markina N.V., Bondar' I.A., Podprugina N.G., Ignatieva I.A., Shabel’nikova O.Yu., Dreval' A.V., Antsiferov M.B., Melnichenko G.A., Dedov I.I.

More about the authors

Journal: Problems of Endocrinology. 2019;65(5): 300‑310

Read: 2074 times


To cite this article:

Mokrysheva NG, Mirnaia SS, Dobreva EA, et al. . Primary hyperparathyroidism in Russia according to the registry. Problems of Endocrinology. 2019;65(5):300‑310. (In Russ.)
https://doi.org/10.14341/probl9946

Recommended articles:
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61

References:

  1. Mokrysheva NG. The primary hyperparathyroidism: the actual conception of the issue. Treatment and prevention. 2013;(2):143-152. (In Russ)
  2. Mokrysheva NG, Gulyaeva SS, Rozhinskaya LYa, et al. The severe course of hyperparathyroidism in the elderly: clinical cases. Problems of endocrinology. 2009;55(1);33-35. (In Russ)
  3. Castellano E, Tassone F, Attanasio R, et al. Mild primary hyperparathyroidism as defined in the Italian Society of Endocrinology’s Consensus Statement: prevalence and clinical features. J Endocrinol Invest. 2016;39(3):349-354. https://doi.org/10.1007/s40618-015-0412-6
  4. Bollerslev J, Marcocci C, Sosa M, et al. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol. 2011;165(6):851-864. https://doi.org/10.1530/EJE-11-0589
  5. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81(6):2036-2040. https://doi.org/10.1210/jcem.81.6.8964825
  6. 6.Allerheiligen DA, Schoeber J, Houston RE, et al. Hyperparathyroidism. Am Fam Physician. 1998;57(8):1795-1802.
  7. AACE/AAES Task force on primary hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11(1):49-54. https://doi.org/10.4158/EP.11.1.49
  8. Potts JT, Ackerman IP, Barker CF, et al. Diagnosis and management of asymptomatic primary hyperparathyroidism. National Institutes of Health Consensus Development Conference. October 29-31, 1990. Consens Statement. 1990;8(7):1-18.
  9. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st Century. J Clin Endocrinol Metab. 2002;87(12):5353–5361. https://doi.org/10.1210/jc.2002-021370.
  10. 10.Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):340–350. https://doi.org/10.1210/jc.2008-1758
  11. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-3569. https://doi.org/10.1210/jc.2014-1413
  12. Dedov II, Vasil’eva TO, Rozhinskaia LIa, Mokrysheva NG. Epidemiology of primary hyperparathyroidism. Problems of endocrinology. 2010;56(5):3-7. (In Russ) https://doi.org/10.14341/probl20105653-7.
  13. Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007;22 Suppl 2:V100-V104. https://doi.org/10.1359/jbmr.07s202
  14. Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3580-3594. https://doi.org/10.1210/jc.2014-1415
  15. Dedov II, Melnichenko GYa, Rozhinskaya L.Ya, et al. Clinical recommendations. Primary hyperparathyroidism (PHPT): clinic, diagnostics, differential diagnostics, methods of treatment. Manual for doctors. Moscow: Print; 2017. (In Russ)
  16. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122-1129. https://doi.org/10.1210/jc.2012-4022
  17. Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf). 2009;71(4):485-493. https://doi.org/10.1111/j.1365-2265.2008.03520.x
  18. Mokrysheva NG. Primary hyperparathyroidism: epidemiology, clinic, modern principles of diagnosis and treatment. [dissertation abstract] Moscow; 2011. 44 p. (In Russ) http://medical-diss.com/medicina/pervichnyy-giperparatireoz-epidemiologiya-klinika-sovremennye-printsipy-diagnostiki-i-lecheniya.
  19. De Geronimo S, Romagnoli E, Diacinti D, et al. The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol. 2006;155(3):415-420 https://doi.org/10.1530/eje.1.02225
  20. Castellano E, Attanasio R, Boriano A, et al. Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J Clin Endocrinol Metab. 2017;102(11):4148-4152. https://doi.org/10.1210/jc.2017-01080
  21. Mamedova EO, Mokrysheva NG, Rozhinskaya LYa. Characteristics of primary hyperparathyroidism in young patients. Problems of endocrinology, 2018;64(3):163-169. (In Russ) https://doi.org/10.14341/probl9399
  22. Eller-Vainicher C, Chiodini I, Battista C, et al. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res., 2009;24(8):1404-1410. https://doi.org/10.1359/jbmr.090304
  23. Pardi E, Borsari S, Saponaro F, et al. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features. PLoS One, 2017; 12(10):e0186485. https://doi.org/10.1371/journal.pone.0186485
  24. Van Leeuwaarde RS, de Laat JM, Pieterman CR, et al. The future: medical advances in MEN1 therapeutic approaches and management strategies. Endocr Relat Cancer, 2017;2 4(10):T179-T193. https://doi.org/10.1530/ERC-17-0225
  25. Busaidy N, Jimenez C, Habra M, et al. Parathyroid carcinoma: a 22-year experience. Head Neck, 2004;26(8):716-726 https://doi.org/10.1002/hed.20049

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.